Media

Genetic Engineering & Biotechnology News (GEN), the leading life sciences publication, recently interviewed our CEO Daniela Marino. The article reports on CUTISS’s progress with denovoSkin™ and the clinical trials, how the company plans to restore patients’ own skin pigmentation, the key role of automation to meet the scale up challenge, and CUTISS’s global ambitions. “The product we are developing really can replace autografting—the current standard-of-care treatment—not only for severe burns patients but also for other reconstructive surgeries,” said Daniela in the interview. You can read the full article using the link below. Newsroom Link to article

The leading industry media Fierce Biotech reported on the news that CUTISS sent human skin cells into space, for advanced R&D testing on the International Space Station. Our Chief Innovation Officer Vincent Ronfard explained in his interview the reasons for conducting such experiments and what we hope to achieve. The initial round of experiments will look at different dimensions of wound healing. One set of cultures contains wounded tissue, and we will focus on how long it takes a wound to close in microgravity. The second set will be used to study how extracellular matrix formation and collagen production differs between space and Earth. The projects will remain on the space station for four weeks before they’re returned. When asked what was it that provoked CUTISS to take this step into space-based research, Vincent replied: “There are two ways of research: One is very organized, but you’re always in the mainstream, and the other is that you’re opportunistic and you say, ‘Okay, let’s try’. When you don’t set too many boundaries, you may find new things that are important.” You can read the full article using the link below. Newsroom Link to article

Following our presence at Arab Health 2023 we had the opportunity to speak with BioVoice, the top Indian bioscience news magazine. In the interview, our CEO Daniela Marino shared the progress that CUTISS has been making in bioengineering the personalized skin graft denovoSkin, the commercial plans around skin pigmentation, and the exciting innovations in regenerative medicine. You can read the interview in the pdf below, or directly online here. Newsroom Interview (PDF)

CUTISS exhibited at the Arab Health 2023 expo in Dubai and had the opportunity to speak with Gulf Today. Our CEO Daniela Marino talked about how she got into the field, what made her decide to start a company, and the promising innovations that CUTISS is developing in skin tissue engineering, skin pigmentation, and regenerative medicine. The interview and article (“Human skin graft technology restores burn-damaged skin”) was published in a special print edition of Gulf Today. Newsroom Interview

In the latest episode of ‘Newton’, the education program on the Italian television channel Rai Scuola, the focus is on skin – the largest organ of the human body. As a guest on the program Daniela Marino talks about the advances CUTISS is making in bioengineering personalized human skin tissue for patients suffering from severe skin burns and injuries. Skip ahead to the 38min mark to see and hear Daniela speak. Newsroom Interview

More than a year since CUTISS announced the world’s first machine to bioengineer human skin, the news continues to generate interest and excitement. As part of their program focused on Swiss innovation, the broadcaster RTS (Neuchatel) visited CUTISS and CSEM who helped develop the denovoCast machine, to find out how automation can scale-up the production of bioengineered skin tissue. Newsroom Link to reportage

The October issue of PwC Switzerland’s ceo magazine is dedicated to the topic of courage. The courage to make decisions, and the courage to set out on the path of entrepreneurship. Our CEO Daniela was interviewed for this edition where she talked about setting up CUTISS, her ambitions, calculated risks, and outcomes for patients suffering from severe burns. What hurdles did Daniela have to overcome? Read on to find out from page 48 onwards: here Newsroom Interview

The Tribune de Côte d’Azur covered the first ‘Impact Awards’ 2022, a jury-led competition organized by Team Côte d’Azur that recognizes leading companies of the local economic ecosystem. CUTISS Innovation, our French subsidiary, was honored to win the ‘Innovation’ trophy for continued innovation and research into regenerative medicine and skin pigmentation. Our director Cécile Cousin was there to receive the award, while our CIO Vincent Ronfard gave an interview to the Tribune newspaper, providing some insights into what our Innovation lab will focus on. Newsroom Interview

As part of the 25th anniversary celebrations of >>venture>>, Daniela contributed an opinion piece on how we can better nurture startups in Switzerland. Newsroom article le matin dimanche (French)

The Swiss daily business newspaper Agefi published an interview with our CEO Daniela Marino following the announcement that CUTISS started onsite denovoSkin production, at its very own GMP facility. This is an exciting milestone for the company, resulting in greater production flexibility and scale-up opportunities. Newsroom Link to Interview